Can adding RNA sequencing to germline genetic testing improve accuracy and clinical sensitivity over time compared to DNA sequencing alone?

Concurrent sequencing of DNA and RNA to detect the predisposition to hereditary cancer.

MiMedx receives FDA warning letter over Axiofill manufacturing concerns

The FDA has highlighted deviations from current good manufacturing practice for MiMedx’s Axiofill, a placenta-based product which is under review regarding its legal classification. After

January 10, 2024

5 Steps to Retain Ownership for Mid-Size Healthcare Organizations

Sridhar Yerramreddy, CEO & Founder of Steer Health The healthcare landscape is continually evolving, and for mid-sized healthcare organizations, this evolution presents both challenges and

November 10, 2023

New inhibitor drug shows promise in preventing diabetic eye and kidney disease

New research has shown a new type of inhibitor drug could prevent microvascular diabetic complications, such as diabetic eye and kidney disease.

February 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.